SARS-CoV-2 IgG Quantitative ELISA - Qualitative detection of class G antibodies to receptors binding to the surface of the S domain glycoprotein of the SARS-CoV-2 coronavirus by enzyme immunoassay.
Intended Purpose;The medical device is intended for the quantitative determination of class G antibodies to the receptor-binding domain (RBD) of the SARS-CoV-2 surface glycoprotein by ELISA for in vitro diagnostics
Storage;2-8°C / 35.6-46.4°F
Specimen Type;Nasopharyngeal Swab
Total Incubation Time;45–85 minutes
Shelf Life;18 months
Sensitivity;93.1%